Mona S. Jhaveri-Brown
Corporate Officer/Principal bij National Cancer Institute
Profiel
Mona S.
Jhaveri-Brown is Founder and Chief Executive Officer of Foligo Therapeutics, Inc. she is a Member of National Cancer Institute.
Dr. Jhaveri-Brown received a PhD in Biochemistry from Wake Forest University.
Actieve functies van Mona S. Jhaveri-Brown
| Bedrijven | Functie | Begin |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 27-05-2009 |
Eerdere bekende functies van Mona S. Jhaveri-Brown
| Bedrijven | Functie | Einde |
|---|---|---|
Foligo Therapeutics, Inc.
 Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Algemeen Directeur | - |
Opleiding van Mona S. Jhaveri-Brown
| Wake Forest University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |